94 filings
8-K
SKYE
Skye Bioscience Inc
3 Apr 24
Regulation FD Disclosure
5:07pm
8-K
SKYE
Skye Bioscience Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:13pm
8-K
SKYE
Skye Bioscience Inc
4 Mar 24
Skye Bioscience Appoints Dr. Annalisa Jenkins to Board of Directors
4:23pm
8-K
SKYE
Skye Bioscience Inc
12 Feb 24
Other Events
4:18pm
8-K
SKYE
Skye Bioscience Inc
29 Jan 24
Skye Bioscience Announces $50.25 Million Private Placement Equity Financing
8:02am
8-K
1hwi05ur y0yzwbo
5 Dec 23
Entry into a Material Definitive Agreement
5:04pm
8-K
puc6rxr4
6 Nov 23
Amendments to Articles of Incorporation or Bylaws
8:21pm
8-K
jyiv6dblwch p7z73e
3 Oct 23
Departure of Directors or Certain Officers
4:34pm
8-K
0j8wkt3uwhb wkji
7 Sep 23
Skye Bioscience Reverse Stock Split to be Effective on September 8th
1:15pm
8-K/A
hfdlo 0qt
1 Sep 23
Departure of Directors or Certain Officers
12:00am
8-K
bgzwnxh 27gui0chx
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K/A
5jhiorw
27 Mar 23
Departure of Directors or Certain Officers
4:09pm
8-K
zvtu2g0qttmvowi
23 Feb 23
Entry into a Material Definitive Agreement
5:18pm
8-K
vupvp
16 Feb 23
Skye Bioscience Appoints Deborah Charych, PhD to Board of Directors
5:16pm
8-K
36a5jyy9wv n825ro
15 Feb 23
Skye Bioscience Closes Sale of Subsidiary, Verdélite Sciences, to C3 Souvenir Holding, with USD$5.60M Closing Payment
4:26pm
8-K
nbz2ohzil0gg
26 Jan 23
Entry into a Material Definitive Agreement
9:22pm
8-K
yz63nf0olhxey9
6 Jan 23
Entry into a Material Definitive Agreement
4:57pm
8-K
k506t96q
16 Dec 22
Entry into a Material Definitive Agreement
6:40pm
8-K
x7jrf6jbb7
23 Nov 22
Entry into a Material Definitive Agreement
5:23pm
8-K
393fvbp
18 Oct 22
Entry into a Material Definitive Agreement
5:44pm